Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization

References

• World Health Organization. Department of Communicable Disease Surveillance and Response. Hepatitis B 2002; 2:1-76; http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/
   Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27:6550 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.08.048; PMID: 19729084
   PubMed Web of Science ®Google Scholar
• Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28:126 - 35; http://dx.doi.org/10.1093/epirev/mxj010; PMID: 16782778
   PubMed Web of Science ®Google Scholar
• Menzies R, McIntyre P. Vaccine preventable diseases and vaccination policy for indigenous populations. Epidemiol Rev 2006; 28:71 - 80; http://dx.doi.org/10.1093/epirev/mxj005; PMID: 16763071
   PubMed Web of Science ®Google Scholar
• Van Damme P. Hepatitis B: vaccination programmes in Europe--an update. Vaccine 2001; 19:2375 - 9; http://dx.doi.org/10.1016/S0264-410X(00)00457-6; PMID: 11257363
   PubMed Web of Science ®Google Scholar
• Cui FQ. Chinese Prevention Medicine Association; National Immunization Program, Chinese Center for Disease Control and Prevention. [Technical guide for adult hepatitis B immunization in China] Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32:1199 - 203; PMID: 22336599
   PubMedGoogle Scholar
• Du G, Niu J, Liu Z. Survey of HBV infection among the new college students at Shanxi Agriculture University. Journal of Changzhi Medical College 2003; 17:18 - 20
   Google Scholar
• Zeng L. A study on the infect condition of HBV for 3246 freshman and countermeasures research. Journal of Guangzhou Physical Education Institute 2006; 26:88 - 94
   Google Scholar
• Lv F. Analysis outcomes of HBV serum marker in 4932 college students. Health Medicine Research and Practice in Higher Institutions 2006; 3:8 - 9
   Google Scholar
• Huang H. Hepatitis B viral infection status of grade 2008 freshman of Hunan University of technology. Pract Prev Med 2009; 16:406 - 7
   Google Scholar
• Zhu X, Zhang XL, Wang LX. National EPI vaccination and hepatitis B coverage rate and the related factors: results from the 1999 national coverage survey. Chin J Vac Imminization 2000; 6:1 - 5
   Google Scholar
• Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high. Vaccine 2011; 29:2302 - 7; http://dx.doi.org/10.1016/j.vaccine.2011.01.025; PMID: 21277403
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405 - 19; http://www.who.int/wer PMID: 19817017
   PubMedGoogle Scholar
• Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994; 140:734 - 46; PMID: 7942775
   PubMed Web of Science ®Google Scholar
• Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine 2009; 27:6110 - 5; http://dx.doi.org/10.1016/j.vaccine.2009.08.034; PMID: 19716459
   PubMed Web of Science ®Google Scholar
• van der Ploeg CP, Kateman H, Vermeer-de Bondt PE, Verkerk PH. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers]. Ned Tijdschr Geneeskd 2004; 148:1820 - 4; PMID: 15495511
   PubMedGoogle Scholar
• Lee PI, Lee CY. Practical considerations in converting from plasma-derived to recombinant hepatitis B vaccines. BioDrugs 1998; 10:11 - 25; http://dx.doi.org/10.2165/00063030-199810010-00002; PMID: 18020583
   PubMed Web of Science ®Google Scholar
• Guirong S, Jingpu S, Shuqiu L, Qundi Z, Wandi Z, Yuezhong Z, et al. A comparative study of yeast-derived plasma-derived hepatitis B vaccine immunity in adults. Journal of China Medical University 1987; 16:75 - 8
   Google Scholar
• Qirong Z, Jianshe W. Comparison of the efficacy between plasma-derived and recombinant yeast-derived hepatitis B vaccine for interruption of maternal-infantile transmission of hepatitis B infection. Zhonghua Er Ke Za Zhi 2000; 38:682 - 4
   Google Scholar
• Banatvala J, Van Damme P, Van Hattum J, European Consensus Group on Hepatitis B Immunity. Boosters for hepatitis B. Lancet 2000; 356:337 - 8; http://dx.doi.org/10.1016/S0140-6736(05)73618-7; PMID: 11071210
   PubMed Web of Science ®Google Scholar
• Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40:RR-13 1 - 25; PMID: 1835756
   PubMedGoogle Scholar
• John TJ, Cooksley G, Steering Committee for the Prevention and Control of Infectious Diseases in Asia. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?. J Gastroenterol Hepatol 2005; 20:5 - 10; http://dx.doi.org/10.1111/j.1440-1746.2004.03398.x; PMID: 15610440
   PubMed Web of Science ®Google Scholar
• Van Damme P, Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 2007; 5:79 - 84; http://dx.doi.org/10.1016/j.tmaid.2006.04.004; PMID: 17298912
   PubMedGoogle Scholar
• Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo HS, Huang LM, Chen DS, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008; 197:1419 - 26; http://dx.doi.org/10.1086/587695; PMID: 18444799
   PubMed Web of Science ®Google Scholar
• Wang LY, Lin HH. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago. Vaccine 2007; 25:7160 - 7; http://dx.doi.org/10.1016/j.vaccine.2007.07.022; PMID: 17707557
   PubMed Web of Science ®Google Scholar
• Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 2009; 27:1858 - 62; http://dx.doi.org/10.1016/j.vaccine.2009.01.027; PMID: 19186203
   PubMed Web of Science ®Google Scholar
• Chang HC, Yen CJ, Lee YC, Chiu TY, Jan CF. Seroprevalence of hepatitis B viral markers among freshmen--20 years after mass hepatitis B vaccination program in Taiwan. J Formos Med Assoc 2007; 106:513 - 9; http://dx.doi.org/10.1016/S0929-6646(07)60001-1; PMID: 17660140
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53:68 - 75; http://dx.doi.org/10.1093/cid/cir270; PMID: 21653306
   PubMed Web of Science ®Google Scholar
• Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010; 51:1547 - 54; http://dx.doi.org/10.1002/hep.23543; PMID: 20209603
   PubMed Web of Science ®Google Scholar
• Yoshida T, Saito I. Hepatitis B booster vaccination for healthcare workers. Lancet 2000; 355:1464 - 6; http://dx.doi.org/10.1016/S0140-6736(05)74663-8; PMID: 10791552
   PubMed Web of Science ®Google Scholar
• Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009; 27:6613 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.08.007; PMID: 19698812
   PubMed Web of Science ®Google Scholar
• Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000; 19:877 - 85; http://dx.doi.org/10.1016/S0264-410X(00)00224-3; PMID: 11115711
   PubMed Web of Science ®Google Scholar
• Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med 1998; 15:1 - 8; http://dx.doi.org/10.1016/S0749-3797(98)00003-8; PMID: 9651632
   PubMed Web of Science ®Google Scholar
• Koh HJ, Kim SD, Choi JH, Kim SR, Lee JS. [A study of immune response to hepatitis B vaccine & HBV DNA in isolated anti-HBc positive subjects] J Prev Med Pub Health 2005; 38:170 - 4
   PubMedGoogle Scholar
• Ollier L, Laffont C, Kechkekian A, Doglio A, Giordanengo V. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera. J Virol Methods 2008; 154:206 - 9; http://dx.doi.org/10.1016/j.jviromet.2008.09.006; PMID: 18848582
   PubMed Web of Science ®Google Scholar
• Seiskari T, Lehtisaari H, Haapala AM, Aittoniemi J. From Abbott ARCHITECT anti-HBc to Anti-HBc II--improved performance in detecting antibodies to hepatitis B core antigen. J Clin Virol 2010; 47:100 - 1; http://dx.doi.org/10.1016/j.jcv.2009.11.010; PMID: 19962345
   PubMed Web of Science ®Google Scholar
• Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine 2012; 30:4034 - 9; http://dx.doi.org/10.1016/j.vaccine.2012.04.031; PMID: 22531558
   PubMed Web of Science ®Google Scholar
• Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine 2004; 22:607 - 10; http://dx.doi.org/10.1016/j.vaccine.2003.09.001; PMID: 14741151
   PubMed Web of Science ®Google Scholar